These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12511565)
1. The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. Peng Y; Jahroudi N J Biol Chem; 2003 Mar; 278(10):8385-94. PubMed ID: 12511565 [TBL] [Abstract][Full Text] [Related]
2. The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. Peng Y; Jahroudi N Blood; 2002 Apr; 99(7):2408-17. PubMed ID: 11895773 [TBL] [Abstract][Full Text] [Related]
3. The NFY transcription factor mediates induction of the von Willebrand factor promoter by irradiation. Bertagna A; Jahroudi N Thromb Haemost; 2001 May; 85(5):837-44. PubMed ID: 11372677 [TBL] [Abstract][Full Text] [Related]
4. Histone H1-like protein participates in endothelial cell-specific activation of the von Willebrand factor promoter. Wang X; Peng Y; Ma Y; Jahroudi N Blood; 2004 Sep; 104(6):1725-32. PubMed ID: 15150074 [TBL] [Abstract][Full Text] [Related]
5. Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia. Mojiri A; Alavi P; Lorenzana Carrillo MA; Nakhaei-Nejad M; Sergi CM; Thebaud B; Aird WC; Jahroudi N Atherosclerosis; 2019 Mar; 282():1-10. PubMed ID: 30665023 [TBL] [Abstract][Full Text] [Related]
6. Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice. Nassiri M; Liu J; Kulak S; Uwiera RR; Aird WC; Ballermann BJ; Jahroudi N Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1423-9. PubMed ID: 20431063 [TBL] [Abstract][Full Text] [Related]
7. An NF1-like protein functions as a repressor of the von Willebrand factor promoter. Jahroudi N; Ardekani AM; Greenberger JS J Biol Chem; 1996 Aug; 271(35):21413-21. PubMed ID: 8702923 [TBL] [Abstract][Full Text] [Related]
8. Irradiation modulates association of NF-Y with histone-modifying cofactors PCAF and HDAC. Peng Y; Stewart D; Li W; Hawkins M; Kulak S; Ballermann B; Jahroudi N Oncogene; 2007 Nov; 26(54):7576-83. PubMed ID: 17599060 [TBL] [Abstract][Full Text] [Related]
9. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene. Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene. Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170 [TBL] [Abstract][Full Text] [Related]
11. Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice. Kleinschmidt AM; Nassiri M; Stitt MS; Wasserloos K; Watkins SC; Pitt BR; Jahroudi N J Biol Chem; 2008 Feb; 283(5):2741-50. PubMed ID: 18048367 [TBL] [Abstract][Full Text] [Related]
12. Endothelial-cell-specific regulation of von Willebrand factor gene expression. Jahroudi N; Lynch DC Mol Cell Biol; 1994 Feb; 14(2):999-1008. PubMed ID: 7507210 [TBL] [Abstract][Full Text] [Related]
13. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor. Zhou J; Hernandez G; Tu SW; Scholes J; Chen H; Tseng CP; Hsieh JT Cancer Res; 2005 Jul; 65(14):6089-96. PubMed ID: 16024609 [TBL] [Abstract][Full Text] [Related]
14. Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor. Hough C; Cuthbert CD; Notley C; Brown C; Hegadorn C; Berber E; Lillicrap D Blood; 2005 Feb; 105(4):1531-9. PubMed ID: 15498853 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms for transcriptional regulation of human high-affinity IgE receptor beta-chain gene induced by GM-CSF. Takahashi K; Hayashi N; Kaminogawa S; Ra C J Immunol; 2006 Oct; 177(7):4605-11. PubMed ID: 16982898 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation. Kapatos G; Vunnava P; Wu Y J Neurochem; 2007 May; 101(4):1119-33. PubMed ID: 17394555 [TBL] [Abstract][Full Text] [Related]
17. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. Zhang Y; Dufau ML J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390 [TBL] [Abstract][Full Text] [Related]
18. Oct-1 is involved in the transcriptional repression of the von willebrand factor gene promoter. Schwachtgen JL; Remacle JE; Janel N; Brys R; Huylebroeck D; Meyer D; Kerbiriou-Nabias D Blood; 1998 Aug; 92(4):1247-58. PubMed ID: 9694713 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
20. Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylation. Flodby P; Li C; Liu Y; Wang H; Rieger ME; Minoo P; Crandall ED; Ann DK; Borok Z; Zhou B Sci Rep; 2017 Jun; 7(1):3473. PubMed ID: 28615712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]